Telehealth Weight Loss/GLP-1 Prescribing: What Psychiatrists Can Do in Florida

If you’re a psychiatrist or PMHNP watching your patients struggle with weight gain from psychiatric meds—or seeing the explosion of GLP-1 demand—you’ve probably asked yourself: ‘Can I prescribe these medications? Should I?’

The short answer: Yes, in most cases. But like everything in healthcare, the devil’s in the details—state scope-of-practice laws, telehealth restrictions, and evolving standards of care all play a role.

This guide breaks down what you need to know: the legal landscape for prescribing weight-loss medications (including GLP-1s like Wegovy and Ozempic), state-by-state rules, reimbursement realities, and how platforms like Klarity Health can help you integrate weight management into your practice without the regulatory headaches.

Why Psychiatrists Are Entering the Weight-Loss Space

The line between psychiatric and metabolic health has always been blurry. Many of your patients gain significant weight from antipsychotics, mood stabilizers, or atypical antidepressants. Obesity worsens depression, anxiety, and overall quality of life. You’re already monitoring metabolic panels, tracking glucose levels, and managing the fallout from medication-induced weight gain.

So when a medication comes along that addresses weight and shows potential mental health benefits—like GLP-1 receptor agonists (semaglutide, tirzepatide)—it’s natural to ask whether prescribing it falls within your scope.

The clinical rationale is solid. Research shows GLP-1s don’t increase depression or suicidality (despite early media scares). In fact, meta-analyses in JAMA Psychiatry found no link between GLP-1s and psychiatric adverse events—and some studies suggest lower rates of depressive symptoms in treated patients compared to placebo. These medications may reduce inflammation, improve mood regulation, and help with impulse control issues like binge eating.

Dr. Elliott Lewis, a psychiatrist board-certified in obesity medicine, puts it plainly: ‘If we understand that metabolic and mental health are inseparable, then psychiatrists managing obesity makes complete sense—with proper training.’

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Scope of Practice: Can You Legally Prescribe Weight-Loss Meds?

For Psychiatrists (MD/DO)

You have full prescriptive authority in all 50 states. As a licensed physician, you can prescribe FDA-approved weight-loss medications—both controlled substances like phentermine (Schedule IV) and non-controlled drugs like GLP-1 agonists—provided you’re practicing within the standard of care.

The question isn’t legal authority—it’s clinical competency. State medical boards expect you to prescribe within your training and expertise. If you’re venturing into obesity medicine, consider:

• Additional training: Many psychiatrists pursue CME in obesity medicine or even board certification through the American Board of Obesity Medicine (ABOM). You don’t need this to prescribe, but it strengthens your scope defensibility and gives you deeper knowledge of metabolic physiology, nutrition interventions, and pharmacotherapy nuances.

• Collaboration: Even if not legally required, communicating with the patient’s primary care provider ensures you’re not missing underlying endocrine issues (hypothyroidism, Cushing’s) or duplicating care.

• Documentation: Clearly document why you’re prescribing (e.g., ‘Patient gained 40 lbs on quetiapine, now BMI 34 with prediabetes; initiating semaglutide as part of comprehensive metabolic-psychiatric care’).

The bottom line: If you gain the requisite knowledge and follow clinical guidelines, prescribing weight-loss medications is a reasonable extension of your scope—especially when it’s integrated with your existing psychiatric care.

For PMHNPs

It depends on your state. Nurse practitioners face a patchwork of scope-of-practice laws:

• Full Practice Authority (FPA) states (~26 states plus D.C.): You can prescribe independently, including weight-loss medications, without physician oversight. Examples: Washington, Oregon, Arizona, Colorado, New Mexico, Montana, Alaska, Hawaii, Maryland, Maine, Vermont, Rhode Island, Connecticut, New Hampshire.

• Reduced Practice states (~20 states): You need a collaborative agreement or some physician relationship to prescribe. Examples: New York (after 3,600 hours, you can practice independently), Illinois (after 4,000 hours + education, you can get FPA), Pennsylvania (collaboration required).

• Restricted Practice states (~8 states): You must have direct physician supervision. Examples: Texas, Florida, California (transitioning), Alabama, Georgia, South Carolina.

Even in FPA states, there are practical barriers: Some insurers or pharmacies require physician sign-off for high-cost GLP-1 prescriptions, even when not legally required. And if you’re prescribing controlled substances (like phentermine), additional rules may apply.

Specialty scope consideration: As a psychiatric NP, your training emphasized mental health, not metabolic disorders. Most state boards expect you to practice within your education. This doesn’t automatically prohibit weight-loss prescribing—especially if it’s tied to managing medication side effects—but if you’re opening a standalone weight-loss clinic, you’ll want supplemental training (obesity medicine courses, certification) to stay on solid ground.

State-Specific Rules: Where It Gets Complicated

Prescribing authority is only half the equation. Many states have specific regulations for weight-loss medications that apply to both MDs and NPs.

Florida: The Strictest State

Florida’s Board of Medicine has detailed obesity treatment rules:

• BMI criteria: Patients must have BMI ≥30 (or ≥27 with comorbidity) to qualify for anti-obesity drugs.
• Physical exam required: An in-person or telehealth comprehensive exam (history, physical, labs to rule out secondary causes) must occur before prescribing.
• Informed consent: Written consent documenting risks/benefits is mandatory.
• Quarterly follow-ups: Patients on weight-loss meds must be seen at least every 3 months. Missing this can trigger board complaints.
• Consumer Bill of Rights: Patients must receive Florida’s state-mandated brochure on weight-loss treatment.

Controlled substances via telehealth: Florida prohibits prescribing controlled substances (including phentermine) via telemedicine for weight loss. The state’s telehealth law exempts psychiatric treatment, inpatient care, and addiction medicine—but weight management isn’t on that list. So if you’re treating a Florida patient remotely, you can prescribe GLP-1s (not controlled) but not phentermine unless you’ve seen them in person.

NP authority: Florida requires all APRNs (including PMHNPs) to work under physician protocol. There’s no independent prescribing of weight-loss drugs for NPs, even if they have the ‘autonomous’ registration (which excludes psychiatric NPs and controlled substances anyway).

Texas: Collaboration Required

Texas mandates Prescriptive Authority Agreements for all NPs and PAs. For weight-loss prescribing:

• The PAA must explicitly authorize the NP to prescribe weight-loss medications (both controlled and non-controlled).
• Monthly quality review meetings and chart audits are required.
• One physician can supervise up to 7 APRNs in non-hospital settings.

Telehealth: Texas allows telehealth prescribing (including controlled substances during the federal waiver period), but standard-of-care documentation is critical. Providers must check Texas’s Prescription Monitoring Program (PMP) for controlled substances.

Corporate Practice of Medicine: Texas strictly prohibits non-physicians from owning medical practices. Weight-loss clinics must have physician ownership or use Management Services Organization (MSO) structures with physician medical directors.

California: Transitioning to NP Independence

California is phasing in NP Full Practice Authority via AB 890:

• Current: NPs need physician-approved standardized procedures for prescribing.
• 2023-2026: ‘103’ NPs (working in group settings) can practice without physician supervision after a 3-year/4,600-hour transition period.
• Jan 1, 2026: ‘104’ NPs can open independent practices.

But: California’s Corporate Practice of Medicine doctrine remains. Only physicians can own medical clinics, so even independent NPs must work within physician-owned entities or professional corporations.

Weight-loss prescribing: MDs have full authority. NPs under protocols can prescribe GLP-1s and other legend drugs, but controlled substances (like phentermine) require physician oversight until full FPA is granted.

New York, Pennsylvania, Illinois: Varied Collaboration Models

• New York: Reduced practice state. NPs need collaboration initially; after 3,600 hours, they can practice independently (including prescribing). No special state rules for weight-loss medications beyond standard of care. I-STOP law requires checking the state PMP for all controlled substances.

• Pennsylvania: Collaboration required. CRNPs must have a written agreement with a physician (up to 4 NPs per MD). Prescriptions must list both the NP’s and physician’s names. No special obesity rules, but collaboration agreements should specify if NP can prescribe controlled weight-loss drugs.

• Illinois: Partial FPA. After ≥4,000 hours + 250 CE hours, APRNs can apply for Full Practice Authority and prescribe independently (including controlled substances, with some Schedule II consultation requirements). Illinois Medicaid reimburses APRNs at 100% of physician rates—a major financial incentive.

Telehealth Restrictions: The Federal-State Divide

Federally, the DEA extended COVID-era waivers through December 31, 2025, allowing providers to prescribe controlled substances via telehealth without a prior in-person exam. But state law can override federal rules.

States with telehealth controlled-substance bans:

• Florida: No controlled substance prescribing via telehealth for weight loss (psychiatric treatment is exempt).
• Alabama: Requires in-person exam for any controlled substance prescription.
• Idaho, South Carolina: Similar restrictions.

The compliance trap: Some telehealth providers assume the federal waiver gives them a green light everywhere. It doesn’t. Approximately 42 states align with federal flexibility, but ~8 states maintain stricter rules. Always check your state’s laws before prescribing controlled substances remotely.

For GLP-1s (non-controlled): These can generally be prescribed via telehealth in all states, as long as you establish a valid patient relationship and meet standard-of-care requirements (appropriate evaluation, informed consent, follow-up plan).

Reimbursement: Can You Get Paid for This?

Weight-loss medication management is becoming more financially viable as insurance coverage expands.

Medication Coverage

Commercial insurance: Most major insurers now cover FDA-approved weight-loss medications (Wegovy, Saxenda, Mounjaro) with prior authorization. Typical criteria:

• BMI ≥30 (or ≥27 with comorbidity)
• Documentation of lifestyle interventions (diet, exercise)
• Regular follow-up with prescriber

Some insurers impose quantity limits—for example, Blue Cross Blue Shield Texas introduced a 30-day supply limit for new GLP-1 prescriptions to monitor adherence before approving refills.

Medicare/Medicaid: Historically, Medicare excluded weight-loss drugs. That’s changing. In late 2024, the Biden administration proposed Medicare coverage of anti-obesity medications, and in November 2025, Medicare announced it will begin covering weight-loss drugs like Wegovy and Mounjaro. This is a game-changer, opening treatment to millions of seniors.

State Medicaid programs vary—some already cover at least one GLP-1 for obesity; others are expected to follow Medicare’s lead.

Billing for Visits

For medication management visits, you’ll use standard E/M codes (99202-99215 series) or psychiatric evaluation codes (90792 for initial, 90833/90836 for med management with therapy). Complexity and time determine the code level.

Telehealth parity: Many states mandate that insurers reimburse telehealth visits at the same rate as in-person:

• California, New York, Illinois, Pennsylvania all have telehealth parity laws for commercial plans.
• Medicare continues reimbursing telehealth mental health visits at office rates (extended through 2025 and likely beyond).

Reimbursement rates:

• Psychiatrists (MD/DO): 100% of physician fee schedule (e.g., Medicare pays ~$100-150 for a 15-20 minute med check, CPT 99213/99214).
• PMHNPs: Medicare reimburses at 85% of physician rates when billing under the NP’s NPI. Some private insurers pay 85-100%. Illinois Medicaid pays NPs at 100% of physician rates—a progressive policy.

Bottom line: If you’re managing weight-loss medications as part of psychiatric care (combining med management for depression/anxiety with metabolic interventions), you can bill higher-complexity E/M codes. If it’s a pure weight-loss visit, use standard codes and document appropriately (BMI, counseling provided, medication risks discussed).

The Economics: Why Platforms Like Klarity Make Sense

Here’s the reality check: acquiring patients for a weight-loss practice through traditional marketing is expensive and uncertain.

The True Cost of DIY Patient Acquisition

Many providers assume they can build a practice cheaply through SEO, Google Ads, or directory listings. Here’s what it actually costs:

SEO: 6-12 months of consistent investment ($2,000-5,000/month for content, technical optimization, link building) before you see meaningful patient flow. Most solo providers don’t have the budget or patience.

Google Ads: Mental health and weight-loss keywords cost $15-40+ per click. Most clicks don’t convert. A realistic cost per booked patient through PPC is $200-400+ after accounting for ad spend, click waste, and no-shows.

Directory listings: Psychology Today, Zocdoc, and similar platforms charge monthly fees ($30-100+) and you compete with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking, but total monthly cost (subscription + per-booking fees) adds up. And you’re still responsible for converting leads—many don’t show up.

Agency/consultant fees: If you hire a marketing agency to manage all this, expect $3,000-5,000/month with no guaranteed results. Failed campaigns, wasted spend, and months of testing are the norm.

Total reality: When you factor in all costs—ad spend, consultant fees, staff time to handle and qualify leads, no-show rates from cold leads—acquiring a qualified psychiatric or weight-loss patient through DIY marketing typically costs $200-500+ per patient. And that’s if you succeed. Many providers spend months and thousands of dollars with zero ROI.

The Klarity Model: Pay Only for Qualified Patients

Klarity Health flips the economics. Instead of gambling on marketing channels with uncertain results, you pay only when a qualified patient books with you.

How it works:

• No upfront marketing spend: Klarity handles patient acquisition through its platform. You don’t pay for ads, SEO, or directory fees.
• Pre-qualified patients: Patients are already matched to your specialty, availability, and whether they’re seeking insurance-based or cash-pay care.
• Standard listing fee per patient: You pay a fee per new patient lead (similar to Zocdoc’s per-booking model). The difference? Klarity’s patients are higher-quality because they’ve already been through a matching process.
• Built-in telehealth infrastructure: No need for separate platform subscriptions (Zoom, Doxy, etc.). Klarity provides the tech.
• Both insurance and cash-pay flow: You can see insured patients (Klarity handles credentialing) or cash-pay patients for weight-loss services.
• You control your schedule: Only pay when you see patients. Take on as many or as few as you want.

The economic advantage: Instead of risking $3,000-5,000/month on marketing with uncertain ROI, you pay a known, predictable cost only when a patient shows up. That’s guaranteed ROI vs. gambling on marketing channels.

For providers scaling a weight-loss practice or integrating metabolic care into psychiatry, Klarity removes the biggest barrier: patient acquisition. You focus on clinical care; Klarity focuses on filling your schedule.

Clinical Protocols: How to Prescribe Safely and Compliantly

Whether you’re prescribing phentermine, GLP-1s, or other weight-loss medications, following clinical best practices protects you from regulatory scrutiny and ensures patient safety.

Initial Evaluation

Document the following:

• BMI calculation: Most states and payers require BMI ≥30 (or ≥27 with comorbidity like diabetes, hypertension) to justify anti-obesity medications.
• Medical history: Screen for contraindications (e.g., GLP-1s are contraindicated in patients with medullary thyroid cancer history or MEN2 syndrome).
• Labs: Check fasting glucose, HbA1c, lipid panel, TSH, liver function (especially if using GLP-1s long-term).
• Mental health screening: Required in some states (like New Jersey). Also ensures you’re addressing any underlying depression, binge-eating disorder, or body dysmorphia.
• Prior weight-loss attempts: Document diet/exercise history, previous medications tried. Many insurers require this for prior authorization.

Informed Consent

At minimum, discuss:

• Expected weight loss (typically 10-15% body weight with GLP-1s over 6-12 months)
• Side effects (GI upset with GLP-1s, insomnia/tachycardia with phentermine)
• Off-label use if applicable (e.g., prescribing Ozempic for obesity when Wegovy is the approved version—some states like Mississippi prohibit this)
• Need for lifestyle changes (medication alone won’t work)
• Follow-up schedule

Document the conversation in the chart. Some states (Florida) require written informed consent forms.

Monitoring and Follow-Up

State-mandated schedules:

• Florida: Every 3 months minimum.
• Virginia: Within 30 days of starting, then monthly initially.
• General best practice: Monthly for the first 3 months (especially with GLP-1s to monitor GI side effects and adjust dosing), then every 2-3 months once stable.

What to monitor:

• Weight, blood pressure, heart rate (especially with phentermine)
• Compliance and tolerance
• Mental health status (mood, suicidality screening—even though GLP-1s don’t increase risk, it’s good practice)
• Labs periodically (glucose, kidney function if on GLP-1s long-term)

PDMP Checks (Controlled Substances)

If prescribing phentermine or other controlled substances, most states require checking the Prescription Drug Monitoring Program before each prescription:

• Mandatory in: Florida (E-FORCSE), Texas, New York (I-STOP), Illinois, California, Pennsylvania, and most others.
• Document the check in your chart (date, what you found, clinical decision).

Compounded Medications: Proceed with Caution

Some telehealth companies use compounded semaglutide to offer cheaper options. Be careful. The FDA and state boards are cracking down:

• Alabama warned providers that compounded semaglutide from non-FDA-registered facilities or using non-approved salt forms (semaglutide sodium) is prohibited.
• Mississippi banned off-label prescribing of GLP-1s for weight loss (you must use FDA-approved obesity versions like Wegovy, not Ozempic).

If you prescribe compounded meds: Ensure the pharmacy is a licensed 503A or 503B facility, uses pharmaceutical-grade ingredients, and complies with FDA shortage policies (compounding is only legal when there’s a genuine shortage of the commercial product).

FAQ: Your Top Questions Answered

Can psychiatrists prescribe Ozempic or Wegovy for weight loss?

Yes. Psychiatrists (MD/DO) have full prescriptive authority in all states. You can prescribe FDA-approved weight-loss medications like Wegovy (semaglutide 2.4mg) or off-label Ozempic if clinically appropriate. However, some states (like Mississippi) prohibit off-label GLP-1 use for obesity, so always check state rules. Best practice: prescribe the FDA-approved obesity version (Wegovy, Saxenda, Mounjaro when approved).

Can PMHNPs prescribe weight-loss medications independently?

It depends on your state. In ~26 Full Practice Authority states, yes—PMHNPs can prescribe independently. In other states, you’ll need physician collaboration or supervision. Even in FPA states, some insurers or pharmacies may require physician involvement for high-cost GLP-1 prescriptions.

Do I need extra certification to prescribe GLP-1s?

No legal requirement, but additional training is recommended. Many psychiatrists pursue obesity medicine CME or board certification through the American Board of Obesity Medicine (ABOM). This strengthens your clinical competency and scope defensibility. For NPs, supplemental training is especially important if weight management falls outside your psychiatric specialty focus.

Can I prescribe weight-loss medications via telehealth?

Generally yes, with exceptions:

• GLP-1s (non-controlled): Allowed in all states via telehealth, as long as you establish a valid patient relationship and meet standard of care.
• Phentermine (controlled): Allowed in most states during the federal DEA waiver period (through Dec 31, 2025). Exception: Florida prohibits telehealth prescribing of controlled substances for weight loss. Alabama and a few other states have similar restrictions. Always verify state law.

What if the federal telehealth waiver expires?

If Congress doesn’t extend the DEA waiver beyond 2025, providers would need an in-person exam before prescribing controlled substances (phentermine). GLP-1s and other non-controlled weight-loss meds would still be fine via telehealth. Many expect the waiver to be extended given bipartisan support and ongoing provider shortages.

How do I bill insurance for weight-loss visits?

Use standard E/M codes (99202-99215) based on visit complexity. If combining psychiatric med management with weight-loss care, document both issues and bill the appropriate level. For Medicare obesity counseling, you can use G0447 (15-minute face-to-face behavioral counseling), though most psychiatric providers stick with E/M codes. Always use the obesity diagnosis code (E66.x) as primary or secondary on claims for weight-related visits.

What’s the reimbursement for weight-loss medication management?

It varies by payer and visit complexity:

• Medicare pays ~$75-150 for a typical med management visit (CPT 99213/99214).
• Private insurers pay similar or higher rates depending on contract.
• NPs are reimbursed at 85-100% of physician rates (some Medicaid programs like Illinois pay NPs at 100%).

Medication costs are separate—GLP-1s can cost $1,000-1,300/month without insurance, but most commercial plans now cover them with prior authorization. Medicare coverage is rolling out in 2026.

What states are hardest for telehealth weight-loss prescribing?

Florida (no controlled substances via telehealth for weight loss), Alabama (in-person exam required for controlled substances), and Texas (strict NP collaboration requirements, strong Corporate Practice of Medicine rules). California and Pennsylvania have moderate complexity due to collaboration requirements and evolving NP scope laws.

Can I open a weight-loss telehealth practice as a PMHNP?

In Full Practice Authority states, yes—but you’ll need to ensure you’re practicing within your competency (consider additional obesity medicine training). In restricted states like Texas, Florida, and California, you’ll need physician collaboration or supervision, and in some cases (CA, TX, FL), physician ownership or medical director oversight due to Corporate Practice of Medicine laws.

What’s the best way to get started without heavy marketing costs?

Join a telehealth platform like Klarity Health. You avoid upfront marketing spend, get pre-qualified patients matched to your availability, and only pay per booked appointment. This eliminates the financial risk of DIY marketing ($3,000-5,000/month with no guaranteed results) and lets you focus on clinical care while the platform handles patient acquisition.

Next Step: Join Klarity’s Provider Network

If you’re ready to integrate weight-loss medication management into your practice—or expand your psychiatric care to include metabolic health—Klarity Health offers the infrastructure, patient flow, and compliance support to make it seamless.

Why providers choose Klarity:

✅ No upfront marketing costs – No gambling on SEO, ads, or directories
✅ Pre-qualified patient flow – Both insurance and cash-pay patients matched to your specialty
✅ Telehealth platform included – No need for separate subscriptions
✅ Compliance support – State-by-state guidance, credentialing assistance
✅ Pay per appointment – Predictable, guaranteed ROI vs. uncertain marketing spend
✅ Flexible scheduling – Control your availability, scale at your pace

Whether you’re a psychiatrist expanding into metabolic psychiatry or a PMHNP building a comprehensive mental health + weight management practice, Klarity removes the biggest barrier: patient acquisition.

Ready to explore? Visit Klarity Health’s provider page to learn more about joining the network, see sample patient volume projections, and connect with the provider success team.

Citations & Sources

1. MedicalDirector Co. – ‘How Much Does a Collaborative Physician Cost for Weight Loss, Telehealth, and Medspas? (2025 Definitive Guide)’ (2025) www.medicaldirectorco.com

2. MedicalDirector Co. – ‘Florida Weight Loss Clinic and Telehealth Compliance Guide (2025)’ (Updated 2025) www.medicaldirectorco.com

3. Florida Administrative Code, Rule 64B15-14.004 – Standards for Prescription of Obesity Drugs (Effective Aug 8, 2022) www.law.cornell.edu

4. Mondaq (Foley & Lardner LLP) – ‘A Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ (July 24, 2023) www.mondaq.com

5. RxAgent.co – ‘Federal Permission, State Prohibition: The 2026 Telehealth Compliance Trap’ (Dec 16, 2025) rxagent.co

Source:

• https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/#:~:text=The%20answer%20is%20almost%20always,yes
• https://www.medicaldirectorco.com/collaborative-physician-cost-weight-loss-telehealth/#:~:text=Nurse%20Practitioners%20
• https://journals.lww.com/tnpj/fulltext/2024/01000/36thannualaprnlegislativeupdate__improving.6.aspx#:~:text=The%20Pennsylvania%20BON%20grants%20CRNPs%2C,more%20physicians%20to%20deliver%20healthcare
• https://journals.lww.com/tnpj/fulltext/2024/01000/36thannualaprnlegislativeupdate__improving.6.aspx#:~:text=The%20Illinois%20Department%20of%20Financial,collaborative%20agreement%20following%20a%20TTP
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20DEA%20gave%20us%20the,evaluation%20at%20the%20federal%20level
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=Despite%20federal%20DEA%20waivers%20extending,traps%20for%20digital%20health%20providers
• https://rxagent.co/blog/telehealth-compliance-trap#:~:text=1.%20Florida%3A%20The%20%22No,for%20Stimulants
• https://www.mondaq.com/unitedstates/healthcare/1447512/a-changing-regulatory-and-reimbursement-landscape-for-weight-loss-drugs#:~:text=New%20Jersey%20law%20requires%20that,and%20identify%20the%20risks%20associated
• https://drlewis.com/glp-1-medications-psychiatry/#:~:text=You%20know%20these%20drugs,disorders%2C%20and%20possibly%20depression%20itself
• https://drlewis.com/glp-1-mental-health/#:~:text=Now%20let%E2%80%99s%20talk%20about%20potential,where%20things%20get%20really%20interesting